Cite
HARVARD Citation
Rogiers, A. et al. (2017). Dabrafenib plus trametinib rechallenge in four melanoma patients who previously progressed on this combination. Melanoma research. 27 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Rogiers, A. et al. (2017). Dabrafenib plus trametinib rechallenge in four melanoma patients who previously progressed on this combination. Melanoma research. 27 (2), p. . [Online].